May 2026

A rapid circuit between primary care centres and Bellvitge Hospital reduces the diagnosis of pulmonary fibrosis from two years to six months

Cardiovascular Diseases Research Group (BIO-HEART), Pneumology , Translational Medicine Area / By

Referred people arrive with greater preserved lung function, allowing treatments to start earlier

A rapid circuit between primary care centres and Bellvitge Hospital reduces the diagnosis of pulmonary fibrosis from two years to six months Read More »

Bellvitge and Sant Joan de Déu identify the genetic variants associated with the most severe forms of Stargardt’s disease

Cellular and molecular basis of sensory disorders, Cross-disciplinary Program in Adult Rare Diseases, Neuroscience Area, Neuroscience Program / By

Stargardt’s disease is a rare disease that causes the loss of central vision, progressively and irreversibly

Bellvitge and Sant Joan de Déu identify the genetic variants associated with the most severe forms of Stargardt’s disease Read More »

Injecting nanoparticles directly into the tumor reinforces radiotherapy in people with cancer who cannot receive chemotherapy

Cancer, Head and neck diseases , Molecular Mechanisms and Experimental Therapy in Oncology Program - Oncobell, Radiobiology & Cancer / By

This strategy increases tumor destruction without increasing damage to healthy tissues.

Injecting nanoparticles directly into the tumor reinforces radiotherapy in people with cancer who cannot receive chemotherapy Read More »

Scroll to Top